WallStSmart

Acco Brands Corporation (ACCO)vsXerox Corp (XRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Xerox Corp generates 394% more annual revenue ($7.76B vs $1.57B). ACCO leads profitability with a 3.7% profit margin vs -11.9%. XRX appears more attractively valued with a PEG of 0.15. XRX earns a higher WallStSmart Score of 60/100 (C).

ACCO

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 5.0Value: 9.3Quality: 4.5
Piotroski: 4/9Altman Z: 0.80

XRX

Buy

60

out of 100

Grade: C

Growth: 6.0Profit: 3.5Value: 8.3Quality: 3.5
Piotroski: 2/9Altman Z: 1.07
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACCOUndervalued (+39.3%)

Margin of Safety

+39.3%

Fair Value

$6.82

Current Price

$4.24

$2.58 discount

UndervaluedFair: $6.82Overvalued
XRXUndervalued (+65.3%)

Margin of Safety

+65.3%

Fair Value

$5.96

Current Price

$3.43

$2.53 discount

UndervaluedFair: $5.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACCO3 strengths · Avg: 9.3/10
P/E RatioValuation
6.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.6x10/10

Reasonable price relative to book value

PEG RatioValuation
0.768/10

Growing faster than its price suggests

XRX3 strengths · Avg: 9.3/10
PEG RatioValuation
0.1510/10

Growing faster than its price suggests

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
22.0%8/10

Revenue surging 22.0% year-over-year

Areas to Watch

ACCO4 concerns · Avg: 2.8/10
Market CapQuality
$387.69M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
3.7%3/10

3.7% margin — thin

Debt/EquityHealth
1.463/10

Elevated debt levels

EPS GrowthGrowth
-51.6%2/10

Earnings declined 51.6%

XRX4 concerns · Avg: 2.5/10
Market CapQuality
$435.96M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-170.0%2/10

ROE of -170.0% — below average capital efficiency

Altman Z-ScoreHealth
1.072/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ACCO

The strongest argument for ACCO centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.76 suggests the stock is reasonably priced for its growth.

Bull Case : XRX

The strongest argument for XRX centers on PEG Ratio, Price/Book, Revenue Growth. Revenue growth of 22.0% demonstrates continued momentum. PEG of 0.15 suggests the stock is reasonably priced for its growth.

Bear Case : ACCO

The primary concerns for ACCO are Market Cap, Profit Margin, Debt/Equity. Thin 3.7% margins leave little buffer for downturns.

Bear Case : XRX

The primary concerns for XRX are Market Cap, Piotroski F-Score, Return on Equity. Debt-to-equity of 7.76 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACCO profiles as a value stock while XRX is a growth play — different risk/reward profiles.

XRX carries more volatility with a beta of 2.46 — expect wider price swings.

XRX is growing revenue faster at 22.0% — sustainability is the question.

XRX generates stronger free cash flow (11M), providing more financial flexibility.

Bottom Line

XRX scores higher overall (60/100 vs 57/100) and 22.0% revenue growth. ACCO offers better value entry with a 39.3% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Acco Brands Corporation

INDUSTRIALS · BUSINESS EQUIPMENT & SUPPLIES · USA

ACCO Brands Corporation designs, manufactures and markets consumer, school, technology and office products. The company is headquartered in Lake Zurich, Illinois.

Xerox Corp

INDUSTRIALS · BUSINESS EQUIPMENT & SUPPLIES · USA

Xerox Holdings Corporation, a workplace technology company, designs, develops and sells document management systems and solutions in the United States, Europe, Canada and internationally. The company is headquartered in Norwalk, Connecticut.

Visit Website →

Want to dig deeper into these stocks?